It was reported that NASH patients had significantly decreased levels of the antiapoptotic protein Bcl-2 and that the degree of apoptosis was inversely correlated with the Bcl-2 level (El Bassat et al., 2014). Here, BCL2 is linked to metabolic dysfunction-associated steatohepatitis.